Previous 10 | Next 10 |
SAN CLEMENTE, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its first quarter 2019 earnings rel...
SAN CLEMENTE, Calif., March 01, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced that Company management will present at the Raym...
The following slide deck was published by ICU Medical, Inc. in conjunction with their 2018 Q4 earnings Read more ...
ICU Medical, Inc. (ICUI) Q4 2018 Earnings Conference Call February 28, 2019, 4:30 pm ET Company Participants John Mills - ICR Vivek Jain - CEO & Chairman Scott Lamb - CFO Conference Call Participants Matthew Mishan - KeyBanc Larry Solow - CJS Securities Jayson Bedfo...
ICU Medical (NASDAQ: ICUI ): Q4 Non-GAAP EPS of $2.07 beats by $0.27 ; GAAP EPS of -$0.36 misses by $1.96 . More news on: ICU Medical, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
SAN CLEMENTE, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced financial results for the quarter ended December ...
ACHC , ADSK , AGO , AIMT , ALRM , ALTR , AMBC , AMC , APPF , AQN , ATRC , BIO , BLDR , CARG , CISN , CSLT , DCO , DDD , DELL , EDIT , EIX , EQH , FTCH , GCAP , GPS , GSBD , HABT , ICUI , JAG , JWN , KTOS , KWR , LYV , MAIN , MAR , MAXR , MTZ , NKTR , N...
ICU Medical (NASDAQ: ICUI ) is scheduled to announce Q4 earnings results on Thursday, February 28th, after market close. The consensus EPS Estimate is $1.80 (-39.6% Y/Y) and the consensus Revenue Estimate is $314.6M (-15.0% Y/Y). Over the last 2 years, ICUI has beaten EPS estimates 8...
NEW YORK, Feb. 11, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Corcept Therapeutics Incorporated (NASDAQ:CORT), CDK Global, Inc. (NASDAQ...
SAN CLEMENTE, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its fourth quarter and fiscal year 2...
News, Short Squeeze, Breakout and More Instantly...
SAN CLEMENTE, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2024 earnings release and conference call. The Company will release its ...
SAN CLEMENTE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2024. First Quarter 2024 Results First...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...